Related Articles
Multimodality therapy and significance of serum CYFRA21-1 for thymic carcinoma
Plasma osteopontin concentrations in patients with cutaneous melanoma
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer
Relationship between miR‑7 expression and treatment outcomes with gefitinib in non‑small cell lung cancer